Literature DB >> 26200258

Pathological differences between white and grey matter multiple sclerosis lesions.

Marloes Prins1, Emma Schul1, Jeroen Geurts1, Paul van der Valk2, Benjamin Drukarch1, Anne-Marie van Dam1.   

Abstract

Multiple sclerosis (MS) is a debilitating disease characterized by demyelination of the central nervous system (CNS), resulting in widespread formation of white matter lesions (WMLs) and grey matter lesions (GMLs). WMLs are pathologically characterized by the presence of immune cells that infiltrate the CNS, whereas these immune cells are barely present in GMLs. This striking pathological difference between WMLs and GMLs raises questions about the underlying mechanism. It is known that infiltrating leukocytes contribute to the generation of WMLs; however, since GMLs show a paucity of infiltrating immune cells, their importance in GML formation remains to be determined. Here, we review pathological characteristics of WMLs and GMLs, and suggest some possible explanations for the observed pathological differences. In our view, cellular and molecular characteristics of WM and GM, and local differences within WMLs and GMLs (in particular, in glial cell populations and the molecules they express), determine the pathway to demyelination. Further understanding of GML pathogenesis, considered to contribute to chronic MS, may have a direct impact on the development of novel therapeutic targets to counteract this progressive neurological disorder.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  grey matter lesion; inflammation; multiple sclerosis; white matter lesion

Mesh:

Year:  2015        PMID: 26200258     DOI: 10.1111/nyas.12841

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  31 in total

Review 1.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

Review 2.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

3.  Exploring reported genes of microglia RNA-sequencing data: Uses and considerations.

Authors:  Thecla A van Wageningen; Emma Gerrits; Sara Palacin I Bonson; Inge Huitinga; Bart J L Eggen; Anne-Marie van Dam
Journal:  Glia       Date:  2021-08-18       Impact factor: 8.073

Review 4.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30

Review 5.  Diversity and Function of Glial Cell Types in Multiple Sclerosis.

Authors:  Lucas Schirmer; Dorothy P Schafer; Theresa Bartels; David H Rowitch; Peter A Calabresi
Journal:  Trends Immunol       Date:  2021-02-13       Impact factor: 16.687

6.  Significant higher-level C-C motif chemokine ligand 2/3 and chemotactic power in cerebral white matter than grey matter in rat and human.

Authors:  Jingdong Zhang; Xinrui Gong; Huangui Xiong
Journal:  Eur J Neurosci       Date:  2021-03-16       Impact factor: 3.698

7.  Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.

Authors:  Laura A N Peferoen; Wouter H Gerritsen; Marjolein Breur; Kimberley M D Ummenthum; Regina M B Peferoen-Baert; Paul van der Valk; Johannes M van Noort; Sandra Amor
Journal:  Acta Neuropathol Commun       Date:  2015-12-22       Impact factor: 7.801

Review 8.  Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.

Authors:  Cecilia Rajda; Dániel Pukoli; Zsuzsanna Bende; Zsófia Majláth; László Vécsei
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

9.  Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.

Authors:  Yiting Liu; Katherine S Given; Danielle E Harlow; Adeline M Matschulat; Wendy B Macklin; Jeffrey L Bennett; Gregory P Owens
Journal:  Acta Neuropathol Commun       Date:  2017-03-24       Impact factor: 7.801

10.  Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes.

Authors:  Noriko Itoh; Yuichiro Itoh; Alessia Tassoni; Emily Ren; Max Kaito; Ai Ohno; Yan Ao; Vista Farkhondeh; Hadley Johnsonbaugh; Josh Burda; Michael V Sofroniew; Rhonda R Voskuhl
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.